昭衍新药
(603127)
| 流通市值：260.75亿 | | | 总市值：311.28亿 |
| 流通股本：6.28亿 | | | 总股本：7.49亿 |
| 日期 |
超大单净流入 |
大单净流入 |
中单净流入 |
小单净流入 |
| 净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
| 2026-07-31 | -6774.67万 | -3.43% | -3719.33万 | -1.88% | -2348.10万 | -1.19% | 12842.11万 | 6.51% |
| 2026-07-30 | -9911.75万 | -4.32% | -17887.48万 | -7.79% | 4305.00万 | 1.88% | 23494.23万 | 10.23% |
| 2026-07-29 | -2118.47万 | -0.83% | -1920.17万 | -0.76% | 984.36万 | 0.39% | 3054.29万 | 1.20% |
| 2026-07-28 | -11250.34万 | -3.46% | -1934.28万 | -0.59% | 7388.29万 | 2.27% | 5796.33万 | 1.78% |
| 2026-07-27 | 20944.80万 | 5.53% | -8898.19万 | -2.35% | -10251.22万 | -2.71% | -1795.39万 | -0.47% |
| 2026-07-24 | -3714.63万 | -1.43% | -13705.25万 | -5.28% | -11968.29万 | -4.61% | 29388.16万 | 11.32% |
| 2026-07-23 | 2325.88万 | 0.79% | 742.41万 | 0.25% | -2054.19万 | -0.70% | -1014.11万 | -0.35% |
| 2026-07-22 | -2952.00万 | -0.83% | -20322.53万 | -5.73% | 7158.14万 | 2.02% | 16116.39万 | 4.54% |
| 2026-07-21 | -14289.43万 | -3.96% | 12637.89万 | 3.50% | 7208.67万 | 2.00% | -5557.13万 | -1.54% |
| 2026-07-20 | 25859.58万 | 5.97% | -5681.64万 | -1.31% | -13019.61万 | -3.01% | -7158.33万 | -1.65% |